Discussion on probiotic bacteria enhance murine and human intestinal epithelial function [2] (multiple letters)

Gastroenterology

Volumn 123, Issue 1, 2002, Pages 391-392

  Kalousek, Markus B ^a  

^a Schötz   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANIMAL CELL; BACTERIAL INFECTION; CELL DIFFERENTIATION; CELL FUNCTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; LETTER; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0036305840     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.34588     Document Type: Article

References (5)

1. K Madsen A Cornish P Soper C McKaigney H Jijon C Yachimec J Doyle L Jewell C DeSimone Probiotic bacteria enhance murine and human intestinal epithelial barrier function Gastroenterology 121 2001 580 591
2. R Lodinova-Zadnikova U Sonnenborn Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants Biol Neonate 71 1997 224 232
3. WA Faubion WJ Sandborn Probiotic therapy with E. coli for ulcerative colitis: take the good with the bad Gastroenterology 118 2000 630 631
4. BJ Rembacken AM Snelling PM Hawkey DM Chalmers AT Axon Non-pathogenic Escherichia coli versus mesalazine for the treatment of uncerative colitis: a randomised trial Lancet 354 1999 635 639
5. W Kruis E Schutz P Fric G Judmaier M Stolte Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis Aliment Pharmacol Ther 11 1997 853 858